Skip to content

HIberCell Targets Forming Dormant Cancer Cells Before They Wake Up

Hibercell, a new biotech company, is focusing on killing off new but dormant cancer cells before they wake up and cause trouble.   Several of the biggest names in biotech venture capital are funding this company with an initial investment of $60 million dollars. HiberCell intends to develop therapies that target dormant cancer cells. Dormant…

Read More

This will close in 0 seconds

Scroll To Top